1,3-dipropyl-8-cyclopentylxanthine has been researched along with substance p in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (75.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cook, MA; McDonald, TJ; Moneta, NA | 1 |
Barlinski, J; Cano, E; Frossard, N; Lagente, V | 1 |
Cook, MA; Deshpande, NA; McDonald, TJ | 1 |
Dassesse, D; Ledent, C; Parmentier, M; Schiffmann, SN | 1 |
4 other study(ies) available for 1,3-dipropyl-8-cyclopentylxanthine and substance p
Article | Year |
---|---|
Endogenous adenosine inhibits evoked substance P release from perifused networks of myenteric ganglia.
Topics: Adenosine; Adenosine Deaminase; Adenosine Triphosphatases; Animals; Biological Transport; Dipyridamole; Ganglia; Guinea Pigs; Ileum; In Vitro Techniques; Myenteric Plexus; Nerve Net; Radioimmunoassay; Receptors, Purinergic P1; Substance P; Tetrodotoxin; Thioinosine; Xanthines | 1997 |
Adenosine reduces airway excitatory non-cholinergic (e-NC) contraction through both A1 and A2 adenosine receptor activation in the guinea pig.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Bronchi; Cholinergic Fibers; Dipyridamole; Dose-Response Relationship, Drug; Electric Stimulation; Guinea Pigs; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Substance P; Theobromine; Vasodilator Agents; Xanthines | 1997 |
Endogenous interstitial adenosine in isolated myenteric neural networks varies inversely with prevailing PO2.
Topics: Adenosine; Animals; Guinea Pigs; Ileum; In Vitro Techniques; Kinetics; Muscle, Smooth; Nerve Net; Oxygen; Partial Pressure; Purinergic P1 Receptor Antagonists; Substance P; Tetrodotoxin; Xanthines | 1999 |
Acute and chronic caffeine administration differentially alters striatal gene expression in wild-type and adenosine A(2A) receptor-deficient mice.
Topics: Animals; Caffeine; Cytoskeletal Proteins; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Administration Schedule; Early Growth Response Protein 1; Enkephalins; Gene Expression Regulation; Genes, Immediate-Early; Glutamate Decarboxylase; Hippocampus; Immediate-Early Proteins; Isoenzymes; Male; Mice; Mice, Knockout; Neostriatum; Nerve Tissue Proteins; Neuropeptides; Phosphodiesterase Inhibitors; Purinergic P1 Receptor Antagonists; Receptor, Adenosine A2A; Receptors, Purinergic P1; RNA, Messenger; Somatosensory Cortex; Substance P; Transcription Factors; Xanthines | 2001 |